Home › Glioma › Massachusetts › Boston

Pag-aaral pangklinika para sa Glioma sa Boston, MA

Isang pag-aaral para sa Glioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MCT for the Harvard/UCSF ROBIN Center

Nagre-recruit

Brigham and Women's Hospital, Boston

Lahat ng edad · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06000787

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Nagre-recruitPhase 1/2

Dana-Farber Cancer Institute, Boston

12 Months – 21 Years · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Nagre-recruitPhase 2

Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute., Boston

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

Dana-Farber Cancer Institute, Boston

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

Susan Chi, Boston

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nagre-recruitPhase 2

Dana-Farber Cancer Institute, Boston

Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Nagre-recruitPhase 1/2

Research Site, Boston

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05417594

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Nagre-recruitPhase 2

Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

CARv3-TEAM-E T Cells in Glioblastoma

Nagre-recruitPhase 1

Massachusetts General Hospital Cancer Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT05660369

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Dana-Farber Cancer Institute, Boston

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2

Dana-Farber Cancer Institute, Boston

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Nagre-recruitMaagang Phase 1

Dana-Farber Cancer Institute, Boston

Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT04655404

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Nagre-recruitPhase 1

Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston

12 Months – 18 Years · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT04943848

CUE-102 in Recurrent Glioblastoma

Nagre-recruitPhase 1

Brigham and Women's Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT06917885

NeuroPathways Intervention for Brain Tumor Patients

Nagre-recruit

Massachusetts General Hospital Cancer Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT05976490

ASCENT Intervention for Brain Tumor Patients

Nagre-recruit

Massachusetts General Hospital Cancer Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2025 · NCT06099743

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

Nagre-recruitObservasyonal na pag-aaral

Massachusetts General Hospital, Boston

Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Peb 22, 2024 · NCT06118723

Pag-aaral para sa Glioma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.